Description

3-Hydroxy-4-[[(2R)-2-Hydroxy-2-(3-Hydroxyphenyl)Ethyl]Methylamino]-4-Oxo-Butanoic Acid is a high-purity, chiral organic compound of significant interest in advanced pharmaceutical synthesis and fine chemical research. Its complex molecular structure, featuring multiple hydroxyl and carbonyl functional groups, makes it a valuable key intermediate and building block for developing novel active pharmaceutical ingredients (APIs). This compound is primarily sought by pharmaceutical R&D teams, contract research organizations (CROs), and manufacturers of specialty fine chemicals for applications in drug discovery and process chemistry.

Application

• Pharmaceutical Intermediate: Serves as a critical chiral synthon in the multi-step synthesis of complex drug molecules, particularly in neurological and metabolic disorder research.
• API Development: Used as a precursor or building block in the research and development of new Active Pharmaceutical Ingredients (APIs) targeting specific receptor sites.
• Biochemical Research: Employed in academic and industrial laboratories as a substrate or ligand for studying enzyme interactions and biochemical pathways.
• Fine Chemical Synthesis: Acts as a starting material for the production of other high-value, structurally complex specialty chemicals with specific optical activity.
• Process Chemistry & Scale-Up: Used in optimizing synthetic routes and developing scalable, cost-effective manufacturing processes for candidate drugs.

Basic Information

Product Name	3-Hydroxy-4-[[(2R)-2-Hydroxy-2-(3-Hydroxyphenyl)Ethyl]Methylamino]-4-Oxo-Butanoic Acid
CAS No.	830346-80-0
Molecular Formula	C14H19NO6
Molecular Weight	297.31 g/mol
Synonyms	(2R)-3-Hydroxy-4-[[2-hydroxy-2-(3-hydroxyphenyl)ethyl]methylamino]-4-oxobutanoic acid; 4-[[(2R)-2-Hydroxy-2-(3-hydroxyphenyl)ethyl]methylamino]-3-hydroxy-4-oxobutanoic acid; Butanoic acid, 3-hydroxy-4-[[(2R)-2-hydroxy-2-(3-hydroxyphenyl)ethyl]methylamino]-4-oxo-; (R)-3-Hydroxy-4-((2-hydroxy-2-(3-hydroxyphenyl)ethyl)(methyl)amino)-4-oxobutanoic acid; A potential intermediate for Rasagiline or related compounds.
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Every batch is characterized and tested using advanced analytical techniques including HPLC, NMR, and chiral analysis to ensure identity, purity, and chiral integrity. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with each shipment. We support development and commercial projects with cGMP-compliant manufacturing options and full traceability documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive). For long-term storage, consider desiccants or storage under an inert atmosphere to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.